Cargando…
DMA, a Small Molecule, Increases Median Survival and Reduces Radiation-Induced Xerostomia via the Activation of the ERK1/2 Pathway in Oral Squamous Cell Carcinoma
SIMPLE SUMMARY: Radiotherapy is commonly used to treat the majority of patients with head and neck cancers. Salivary glands in the radiation field are affected by this procedure. The purpose of this study was to investigate the role of DMA as a radiomodulator to evaluate the real possibilities of re...
Autores principales: | Parashar, Palak, Das, Monoj Kumar, Tripathi, Pragya, Kataria, Tejinder, Gupta, Deepak, Sarin, Deepak, Hazari, Puja Panwar, Tandon, Vibha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562201/ https://www.ncbi.nlm.nih.gov/pubmed/36230831 http://dx.doi.org/10.3390/cancers14194908 |
Ejemplares similares
-
Synthesis and Biological Evaluation of Novel 1H-Benzo[d]imidazole Derivatives
as Potential Anticancer Agents Targeting Human Topoisomerase I
por: Pandey, Stuti, et al.
Publicado: (2022) -
DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells
por: Kaur, Navrinder, et al.
Publicado: (2012) -
Microenvironment Stimulated Bioresponsive Small Molecule
Carriers for Radiopharmaceuticals
por: Chaturvedi, Shubhra, et al.
Publicado: (2020) -
Relief of the Dma1-mediated checkpoint requires Dma1 autoubiquitination and dynamic localization
por: Jones, Christine M., et al.
Publicado: (2018) -
MMA:DMA ratios reversed.
por: Slayton, T
Publicado: (1997)